Genenta Science S.p.A. (GNTA)
Nasdaq: GNTA · Biological Products, (No Diagnostic Substances) · Milan, IT · filing with the SEC since 2021
Who runs Genenta Science S.p.A.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Paracchi Pierluigi
Chief Executive Officer. First filing Mar 2026, latest May 5, 2026, 0 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Paracchi Pierluigi | Chief Executive Officer | Mar 2026 | May 5, 2026 | none |
| Slansky Richard B | Chief Financial Officer | Mar 2026 | Apr 1, 2026 | none |
| Galimi Francesco | CMO& Head of Development | Mar 2026 | Apr 1, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mutti Miguel Maria | director | Mar 2026 | Apr 1, 2026 | none |
| Paracchi Giacomoantonio | director | Mar 2026 | Apr 1, 2026 | none |
| Sharei Armon | director | Mar 2026 | Apr 1, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.